arrow_back Back to App

Support for Pediatric Disease Research: Gabriella Miller Kids First Program Extension

This act extends funding for the Gabriella Miller Kids First Pediatric Research Program until 2028. This means continued vital research into childhood cancer and other conditions, potentially leading to new treatments and improved health for children. Additionally, the act emphasizes avoiding duplication of research, ensuring more efficient use of public funds.
Key points
Funding for pediatric disease research, including cancer, will be extended until 2028, increasing the likelihood of new medical discoveries.
Public funds for research will be used more efficiently by avoiding duplication of existing work.
The government will regularly report on progress and investments in pediatric research, ensuring transparency of expenditures.
article Official text account_balance Process page
VOTING RESULTS
2024-03-06
99%
For 384
Against 4
Abstain 0
Full voting results open_in_new
Became Law
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3391
Sponsor: Rep. Wexton, Jennifer [D-VA-10]
Process start date: 2023-05-16
Voting date: 2024-03-06
Meeting no: 2
Voting no: 60
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Gabriella Miller Kids First Research Act 2.0

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3391.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-16.

What are the main provisions?

Key points include:

  • Funding for pediatric disease research, including cancer, will be extended until 2028, increasing the likelihood of new medical discoveries.
  • Public funds for research will be used more efficiently by avoiding duplication of existing work.
  • The government will regularly report on progress and investments in pediatric research, ensuring transparency of expenditures.
What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. Wexton, Jennifer [D-VA-10].

What is the latest detailed status?

The latest detailed status is: Became Public Law No: 118-228.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health